Eli Lilly
LLY
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 3 hours ago • LLY
Top 15 High-Growth Dividend Stocks For February 2026
CNBC Television • 2 days ago • LLY
Jim Cramer on what is driving Eli Lilly's stock right now
Zacks Investment Research • 2 days ago • LLY
Why the Market Dipped But Eli Lilly (LLY) Gained Today
CNBC • 2 days ago • LLY
Cramer's week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.